INTRODUCTION
Nonossifying fibroma (NOF) was first reported in 1941 by Sontag and Pyle.[1] It is classified as per the histologic classification of bone tumors by the WHO as a nonneoplastic tumor-like lesion.[2,3] It was described as “nonosteogenic fibroma” by Jaffe and Lichtenstein in 1942.[4] Fibrous cortical defect (FCD) and NOFs are synonymously used and represent the most common lesions of the skeletal system[1,5] NOF is most commonly reported in long bones (33% of healthy children exhibit FCD),[7] While the mandibular NOF cases are few.[6,7] NOFs of the jaws are often seen in children of 10–15-year age group, whereas the long bone variant exhibits itself at an earlier age.[8] Long bone NOF lesions show male predilection, while the mandibular lesions show female predilection. NOF of the jaws are asymptomatic or show diffuse swelling at the involved site.[6,8–10] Histologic features show an abundance of fibroblasts laid on connective tissue matrix with giant cells and histiocytes.[7] Traumatic irritation, dystrophic calcification, and growth disturbance are the probable etiologic causes of these lesions.
NOF can be associated with other skeletal anomalies such as Jaffe–Campanacci syndrome,[11] Fanconi syndrome with osteomalacia, and others.[11–13] Differential diagnosis includes fibromatosis, fibrous dysplasia, nonosteogenic fibroma, FCD, aneurysmal bone cyst, neurofibromatosis, cortical desmoid, enchondroma, eosinophilic granuloma, nodular fibrous oral lesions, desmoplastic fibroma, and fibroxanthoma. Surgical intervention is not recommended in nonexpansile, NOFs unless they tend to expand and show a tendency to fracture the involved bone. NOF may or may not be associated with neurofibromatosis.[14,15] Although the typical radiographic features and clinical presentation of NOF suggest the condition, a definitive diagnosis is confirmed by histological examination.[16] A treatment plan is based on the stage of NOF to prevent bone fracture. Staging or fracture risk assessment for NOF of the jaws can be referred from Ritschl[17–19] fracture risk criteria. The author categorized fibrous metaphyseal defect of long bones accordingly: Stage A: a small, oval-polycyclic eccentric corticular lesion near the epiphyseal plate without a sclerotic border; Stage B: a polycyclic-shaped lesion with thin but clear sclerotic borders, thinning the cortex, usually away from the epiphysis, sometimes showing protrusion without periosteal reaction, resembling hourglass shape; Stage C: Stage A and Stage B resemble each other with diffuse sclerosis extending from diaphysis; and Stage D: total sclerosis of the lesion.
CASE REPORT
A 15-year-old female patient complained of pain in the lower right posterior teeth for the past 2 to 3 months. There was no clinical history of patients regarding trauma, medical illness, and gave no relevant familial history. On extraoral examination, a diffuse facial asymmetry [Figure 1] was noted on the left side with no remarkable facial enlargement on the right side. The swelling was nontender and firm on palpation. On intraoral examination, the tumor on the left mandible extended from the distal aspect of the first molar to the anterior border of the ramus of the mandible with vestibular obliteration. A similar finding was noticed with vestibular obliteration on the right lower posterior region of the mandible, extending from the distal of the first molar to the coronoid process. On intraoral palpation, swelling on the lower right side of the mandible was tender, whereas, on the lower left side, it was nontender. The growth on both sides had increased gradually in size. The teeth involved were not carious.
Figure 1: Preoperative photograph of a 15-year-old patient with NOF showing diffuse enlargement of the left side of the face. NOF: Nonossifying fibroma
Radiographic findings showed multilocular radiolucencies with mandibular buccal and lingual cortical bone expansion on the right and left sides, extending from the distal of the first molar to the coronoid process on the right and extending from the first molar to the ascending border of the ramus anteroposteriorly, expanding but not fracturing the buccal and lingual cortical plates mediolaterally with a resultant shift of the mandibular canal toward the lower border of the mandible, sparing approximately 1 cm of the lower border of the mandible. There was no resorption of the bone surrounding the roots of the involved teeth [Figures 2a, b, 3, and 4].
Figure 2: (a and b) CBCT and 3D reconstruction of the skull showing bilateral multilocular NOF. CBCT: Cone-beam computed tomography, NOF: Nonossifying fibroma
Figure 3: CBCT axial view. CBCT: Cone-beam computed tomography
Figure 4: Panoramic view
Treatment
Surgical excision and curettage of the lesion was done [Figure 5a and b].Post-op intraoral sutures and the excised NOF specimen is shown in Figure 6 and 7 respectively. However, NOF on the left side showed no recurrence [Figure 5a and b]. Postoperative healing was uneventful [Figure 8].
Figure 5: (a and b) Surgical excision and curettage
Figure 6: Excised specimen
Figure 7: Closure of the excision site with sutures
Figure 8: Wound healing at the site
Prognosis
Prognosis depends on the recurrence and extension of the expansile lesion with or without a bone fracture or intrusion on the adjacent vital structures. If the bone involved is medullary, without the involvement of peripheral bone, the prognosis is good. Some lesions show spontaneous regression without any surgical intervention.
DISCUSSION
Differential diagnosis
Radiologic findings of polyostotic fibrous lesions and NOFs display similar characteristics. Histological findings help in differentiating the two. Neurofibromatosis and NOFs share similar clinical characteristics. NOFs and congenital fibromatosis radiographically resemble each other, but the latter is more prevalent in the spine and ribs. Lymphangiomatosis and cystic hemangiomatosis of the bone involve diaphyseal bone and viscera, thus differentiating from NOF of the jaws. If a patient with neurofibromatosis exhibits multiple lytic lesions on the radiograph, it is suggestive of NOF. Since NOF and fibrous cortical bone defects show ossification defects, they cannot be strictly categorized as true neoplasms.[20–22] FCDs and NOFs exhibit similar characteristics, but FCDs are smaller compared to NOFs radiographically. NOFs are synonymously called fibroxanthoma, FCD, or benign fibrous histiocytoma.[11] NOF can be differentiated from odontogenic and nonodontogenic tumors clinically, radiographically, and histopathologically.[23]
Associated syndromes/diseases
Extraskeletal congenital anomalies such as café-au-lait spots and other signs of neurofibromatosis, mental retardation, hypogonadism or cryptorchidism, ocular anomalies or cardiovascular malformations, Jaffe–Campanacci syndrome, fanconi syndrome with osteomalacia may be associated with NOF.[11,12,24] Reports also show NOF association with congenital eye defects such as pigmentary dispersion of the retina, cataract, eyelid malformation, papillary collaboma, dermolipoma of the conjunctiva, alopecia, kyphoscoliosis, precocious puberty, megaureter, epiphysiolysis, and knee deformities.[24,25] Cardiovascular defects associated with NOF include aortic isthmus, stenosis, and mitral insufficiency. 6.7% of nonsyndromic NOFs showed recurrence in comparison with a higher rate of about 60% recurrence in syndromic NOFs.[26] Syndromic forms are, however, less prevalent than nonsyndromic counterparts.[26]
Treatment options
Treatment options depend on the presentation of the tumor. Its association with syndromes shows high chances of recurrence, thus calling for a vigorous surgical removal with curettage and bone graft.
CONCLUSION
A sound clinical-histopathological knowledge of the lesion helps in differentiating rare NOF of the jaws from similar jaw lesions. Timely surgical intervention helps in preventing pathological fracture of the jaws. Surgical excision with curettage and bone grafting, if needed, is the treatment of choice.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initials will not be published and due efforts will be made to conceal her identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Sontag LW, Pyle DI. The appearance and nature of cyst-like areas in distal femoral metaphyses of children. Am J Roentgenol Radiat Ther 1941;46:185–8.
2. Schajowicz F, Sissons HA, Sobin LH. International Histological Classification of Tumors (Histological Typing of Bone Tumors) Geneva World Health Organization 1993.
3. Mizukawa N, Nishijima Y, Nishijima K. Metaphyseal fibrous defect (nonossifying fibroma) in the mandible. A case report. Int J Oral Maxillofac Surg 1997;26:129–30.
4. Jaffe HL, Lichtenstein L. Non-osteogenic fibroma of bone. Am J Pathol 1942;18:205–21.
5. Betsy M, Kupersmith LM, Springfield DS. Metaphyseal fibrous defects. J Am Acad Orthop Surg 2004;12:89–95.
6. Park JK, Levy BA, Hanley JB Jr. Non-ossifying fibroma of the mandible:Report of a case. J Baltimore Coll Dent Surg 1982;35:1–5.
7. Hudson JW, Livesay KW, McCoy JM. Condylar lesion. J Oral Maxillofac Surg 2003;61:824–6.
8. Bailey JS, Nikitakis NG, Lopes M, Ord RA. Nonossifying fibroma of the mandible in a 6-year-old girl:A case report and review of the literature. J Oral Maxillofac Surg 2001;59:815–8.
9. Rudy HN, Scheingold SS. Solitary xanthogranuloma of the mandible;report of a case. Oral Surg Oral Med Oral Pathol 1964;18:262–71.
10. Liaw WJ, So TK, Yao YT. Nonossifying fibroma of the mandible –A case report. Taiwan Yi Xue Hui Za Zhi 1979;78:795–802.
11. Mankin HJ, Trahan CA, Fondren G, Mankin CJ. Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome:A biologic and clinical review. Chir Organi Mov 2009;93:1–7.
12. Leehey DJ, Ing TS, Daugirdas JT. Fanconi syndrome associated with a non-ossifying fibroma of bone. Am J Med 1985;78:708–10.
13. Evans GA, Park WM. Familial multiple non-osteogenic fibromata. J Bone Joint Surg Br 1978;60-B:416–9.
14. Goodnough CP, Kuhlmann RP, Stark E. Von Recklinghausen's neurofibromatosis;with nonosteogenic fibroma. N Y State J Med 1975;75:2407–9.
15. Mandell GA, Dalinka M, Mankin HJ, Trahan CA. Non-ossifying fibroma, fibrous cortical defect, and Jaffe-Campanacci syndrome:A biologic and clinical review. Musculoskelet Surg 2009;93:1–7.
16. Mallet JF, Rigault P, Padovani JP, Touzet P, Nezelof C. Non-ossifying fibroma in children:A surgical condition?. Chir Pediatr 1980;21:179–89.
17. Ritschl P, Karnel F, Hajek P. Fibrous metaphyseal defects –Determination of their origin and natural history using a radiomorphological study. Skeletal Radiol 1988;17:8–15.
18. Błaż M, Palczewski P, Swiątkowski J, Gołębiowski M. Cortical fibrous defects and non-ossifying fibromas in children and young adults:The analysis of radiological features in 28 cases and a review of literature. Pol J Radiol 2011;76:32–9.
19. Monettin LB, Mueller E, Schneider M. Generalized hamartomatous (congenital generalized fibromatosis). AJR 1972;14:722–34.
20. Akai M, Tateishi A, Cheng CH, Morii K, Abe M, Ohno T, et al. Membranous lipodystrophy:A clinicopathological study of six cases. J Bone Joint Surg Am 1977;59:802–9.
21. Dahlin DC. Bone Tumors 2
nd ed Springfield, IL Thomas 1967 9.
22. Bowers LM, Cohen DM, Bhattacharyya I, Pettigrew JC Jr, Stavropoulos MF. The non-ossifying fibroma:A case report and review of the literature. Head Neck Pathol 2013;7:203–10.
23. Campanacci M, Laus M, Boriani S. Multiple non-ossifying fibromata with extraskeletal anomalies:A new syndrome?. J Bone Joint Surg Br 1983;65:627–32.
24. Pitcock JA. Tumors and tumor-like lesions of bone Crenshaw AH. Campbell's Operative Orthopedics 5
th ed St Louis CV Mosby 1971 1333–411.
25. Jamshidi K, Motaghi P, Bagherifard A, Eigi M, Al-Baseesee HH, Mirzaei A. Comparison of characteristic features and local recurrence in syndromic versus non-syndromic multifocal non-ossifying fibroma. J Orthop Sci 2021;26:655–9.
26. Herget GW, Mauer D, Kraub T, El Tayeh A, Uhl M, Südkamp NP, et al. Non-ossifying fibroma:natural history with an emphasis on a stage-related growth, fracture risk and the need for follow-up. BMC Musculoskeletal Disorders 2013 17 doi:10.1186/s12891-016-1004-0.